There is a simple way to understand CitiusTech: imagine an IT-services company that kept saying no. No to banks. No to retailers. No to airlines, telecoms and the dozen other verticals that make a sales pipeline look comforting. Since 2005, the company has stayed inside healthcare and life sciences, where software must negotiate with old records, newer regulations, nervous security teams and the stubborn fact that a broken workflow can affect a patient.
That narrowness is the product. CitiusTech now employs more than 7,700 healthcare technology professionals and says more than 140 enterprises use its work, including 40 percent of Fortune 500 healthcare companies. It builds and modernizes software for health plans, hospital systems, medical-device makers and life-sciences companies. It connects clinical data, migrates workloads to the cloud, engineers digital products, runs analytics and manages technology after launch. More than 650 medical and clinical professionals sit inside the organization - an unusual bench for a business that still looks, from a distance, like outsourced engineering.
The original wagerDepth before scale
Founders Rizwan Koita and Jagdish Moorjani had already built and sold TransWorks, a business-process outsourcing company, when they started CitiusTech with Bimal R. Naik in 2005. Naik brought healthcare experience; Koita and Moorjani brought the muscle memory of building a services operation. Their more consequential choice was not the technology. It was the boundary: healthcare only.
They did not immediately decorate that thesis with venture capital. CitiusTech took its first institutional investment nine years later. By 2014 it had roughly 1,400 employees, about $75 million in reported revenue and a flagship analytics product, BI-Clinical, installed at more than 3,800 provider locations. General Atlantic’s investment - reported around $100 million, though the official announcement did not disclose terms - arrived after the company had proved the specialty could scale.
The moat is not knowing how to code. It is knowing which healthcare constraint will ambush the code next.YesPress analysis
That history explains why CitiusTech is different from a generalist such as Accenture, Cognizant, Infosys, TCS or Wipro. Those firms can offer broader procurement relationships, larger global benches and one contract across many industries. CitiusTech’s counteroffer is context: engineers who already speak FHIR and HL7, quality teams who understand HEDIS and CMS Stars, imaging specialists who know interoperability, and consultants accustomed to the privacy and audit demands surrounding clinical data.
From specialist crew to global bench
Selected company-reported milestones. Figures reflect different reporting dates and acquisition scopes.
What it sellsServices discovered the pain. Products package it.
The business model begins with enterprise contracts: consulting, product engineering, data integration, cloud modernization, quality assurance, cybersecurity and managed services. Prices are not public. This is negotiated work whose cost depends on systems, data, integrations, compliance and how much of the operation CitiusTech will run. Anyone looking for a credit-card checkout page has taken a wrong turn.
But CitiusTech is no longer only selling skilled hours. Its PERFORM+ family turns recurring payer and provider problems into software. Contracts centralizes value-based arrangements, provider goals and incentives. Stars uses machine learning for Medicare Advantage performance planning. Regulatory coordinates quality measures, record review, submission and gap closure. RealSight analyzes public price-transparency files. DataScale creates a common data foundation. In 2024, the clinical convergence platform added a generative-AI HEDIS workflow for the decidedly unglamorous work of quality measurement.
Work inside the workflow
Long client engagements expose repeated regulatory, data and operational friction.
Turn repetition into IP
Frameworks, accelerators and products replace a portion of bespoke work.
Return with context
Reusable software makes the next engagement faster - and reveals the next problem.
For life-sciences customers, HealthSPARX takes on another plumbing problem: ingesting syndicated claims and other real-world datasets, preparing them for analysis, and supporting research, commercial work and software-as-a-medical-device development. CitiusTech offers it as a platform service. The company argues this can save smaller biopharma firms years and millions otherwise spent building custom analytics infrastructure. That is a vendor claim, not a universal result, but the underlying problem is real: buying data is much easier than making different datasets behave like one system.
The new wagerAI that arrives with paperwork
Knewron, launched in September 2025, is the clearest statement of where CitiusTech wants to sit next. It is a healthcare-native platform for building and operating enterprise AI. The feature list avoids the usual “one model to rule them all” pitch. It includes multiple-model routing, cost awareness, healthcare-specific data ingestion, visual agent workflows, policy enforcement, immutable audit trails, persona-specific workbenches and deployment inside a customer’s private cloud or data center.
The design is an answer to what fails first. In healthcare, it is rarely the demo. It is trust after the demo: unclear data lineage, an answer nobody can explain, a workflow that never reaches the system clinicians use, or a privacy rule discovered too late. CitiusTech’s Quality & Trust framework tests model quality, bias, toxicity and operating efficiency while connecting to MLOps and DataOps monitoring. Microsoft gave that framework a Certified Software Designation for Healthcare AI in January 2026; AWS awarded CitiusTech a generative-AI consulting competency in April.
The proof still has to live in customer outcomes. One useful example is vCision, a revenue-intelligence platform CitiusTech helped Ventra Health engineer. Ventra reported a 19 percent improvement in first-pass payment rates, a 26 percent reduction in initial denials and millions recovered from delayed reimbursement. Those numbers belong to that implementation, with its data and operating conditions. They are evidence of possibility, not a coupon promising the same result everywhere.
What did it cost? Bain Capital’s reported purchase implies roughly $2.4 billion for the whole company at that moment. The money was tied to a secondary stake transaction, not a $960 million product budget or a fresh funding round deposited into CitiusTech.
Ownership, without the fairy taleThe route that failed first
Private equity has been part of the CitiusTech story since General Atlantic entered in 2014. Baring Private Equity Asia bought control in 2019 in a transaction reported to value the company above $1 billion. A U.S. listing through a special-purpose acquisition company was explored in 2021 and later called off. What changed was the route to liquidity, not the healthcare thesis: in 2022 Bain Capital instead bought a reported 40 percent stake from BPEA for about $960 million, with Bain and BPEA taking joint control.
Acquisitions widened the capability stack. FluidEdge added healthcare consulting. SDLC Partners strengthened payer work. Wilco Source brought Salesforce skills for healthcare and life sciences. Health Data Movers, acquired in 2025, added Epic, Workday and ServiceNow implementation depth. The last deal is especially telling. An AI agent is not useful if it floats above the electronic record and asks staff to switch screens. Epic expertise moves CitiusTech closer to the daily systems where intelligence must actually appear.
What to copyPick one hard market. Learn its nouns.
The copyable part of CitiusTech is not “start a healthcare consultancy.” It is the sequence. Choose a market with expensive recurring constraints. Use services to see those constraints at close range. Hire domain experts alongside technologists. Notice which work repeats. Turn that repetition into software, templates and quality systems. Then keep the services arm close enough to stop the product team from inventing a cleaner world than customers inhabit.
The less copyable ingredient is time. Healthcare specialization accumulates through regulations, implementations, failed integrations and earned trust. CitiusTech’s partnerships with AWS, Microsoft, Snowflake, Salesforce and HealthEdge matter because customers rarely replace their entire stack. The specialist has to make a new layer work with whatever is already there.
When this playbook does not work
- The market is too small to support a deep specialist bench.
- Client problems stay bespoke and never become reusable IP.
- The buyer wants a cheap, self-serve tool rather than enterprise change.
- Data is inaccessible, ownership is fuzzy or leaders will not redesign workflows.
- A cross-industry transformation rewards one broad vendor more than healthcare depth.
CitiusTech enters this chapter with a leadership change. In August 2026, longtime executives Dhaval Shah and Shyam Karunakaran became acting CEO and president. Together they have more than 36 years at the company. That is a continuity bet: the new strategy is meant to extend the specialty, not erase it.
The challenge is sharp. General-purpose AI models improve quickly, cloud platforms keep adding healthcare features, and giant consultancies can buy expertise. CitiusTech must prove that two decades of context can be encoded into products that are safer, faster and more useful than a client assembling the pieces itself. Its advantage is not that it discovered AI early. It is that it knows where healthcare technology tends to break - and has spent 20 years being paid to fix it.